BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31770211)

  • 1. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
    Wang B; Wang W; Wang H; Liu W
    Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
    Wu ZH; Zhou T; Sun HY
    Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
    Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
    Gao P; Lu W; Hu S; Zhao K
    Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
    Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.
    Zhong X; Shang J; Zhang R; Zhang X; Yu L; Niu H; Duan X
    PLoS One; 2024; 19(5):e0296034. PubMed ID: 38753689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
    Zhou R; Liu D; Zhu J; Zhang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Wu X; Lin L; Zhou F; Yu S; Chen M; Wang S
    Mol Biotechnol; 2022 Jun; 64(6):621-636. PubMed ID: 35038119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Song Y; Feng T; Cao W; Yu H; Zhang Z
    Comput Intell Neurosci; 2022; 2022():9022700. PubMed ID: 35712071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
    Pan X; Liu JH
    Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
    Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
    Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
    Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
    Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.